Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 1 Trial

Recent news which mentions Phase 1 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
Tickers ALXO
Tags ASH21 News why it's moving
From Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
Tickers VIRX
Tags lymphoma General VIRX
From Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
Tickers HARP
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
Tickers JNJ LEGN
Tags Market News Phase 2 Trial Benzinga
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF lymphoma
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags Health Care Phase 1 Trial gene therapy
From Benzinga
Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients
Tickers ARVN PFE
Tags General News Briefs
From Benzinga
Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way
Tickers BNTX MRNA SNY
Tags Movers why it's moving SNY
From Benzinga
AbbVie, SpringWorks Join Forces To Conduct Multiple Myeloma Combo Therapy Trial
Tickers ABBV SWTX
Tags General News Briefs
From Benzinga
Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
Tickers FREQ
Tags Biotech Phase 1 Trial Health Care
From Benzinga
Ambrx Biopharma Shares Jump After Safety, Efficacy Data From Breast Cancer Trial
Tickers AMAM
Tags Health Care Phase 1 Trial Biotech
From Benzinga
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients
Tickers IDYA
Tags Health Care Phase 1 Trial Small Cap
From Benzinga
Prometheus Biosciences Posts Phase 1 Data On Lead Therapeutic Candidate
Tickers RXDX
Tags Movers News Briefs
From Benzinga
Inventiva Posts Results of Clinical Thorough QT Study Of Lanifibranor
Tickers IVA
Tags General IVA Briefs
From Benzinga
Adagene's Posts Early Safety, Efficacy Data From Cold Tumors Trial
Tickers ADAG
Tags General Solid Tumor Briefs
From Benzinga
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
Tickers BLCM
Tags prostate cancer General BLCM
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
Tickers IMCR RHHBF RHHBY RHHVF
Tags Health Care Biotech Small Cap
From Benzinga
Adicet Stock Rallies After Early Responses For Off-The-Shelf Drug In B-cell Non-Hodgkin's Lymphoma
Tickers ACET
Tags why it's moving News Briefs
From Benzinga
Fulcrum Therapeutics Shares Additional Data From Phase 1 Trial Of Sickle Cell Disease Treatment
Tickers FULC
Tags Small Cap Biotech Phase 1 Trial
From Benzinga
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
Tickers BOLT
Tags General Movers Briefs
From Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
Tickers MOLN
Tags Benzinga Phase 2 Trial Market News
From Benzinga
Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome
Tickers STOK
Tags General Briefs News
From Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
Tickers SQZ
Tags Phase 2 Trial Market News Benzinga
From Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
Tickers INBX
Tags News Briefs General
From Benzinga
Read Why Is Roth Capital Bullish On This Cancer-Focused Stock
Tickers MBRX
Tags Health Care Brain Tumor Biotech
From Benzinga
Arbutus' Hepatitis B Candidate Shows Encouraging Antiviral Activity
Tickers ABUS MRNA
Tags hepatitis B ABUS General
From Benzinga
Mereo BioPharma's Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical Cancer
Tickers BMY MREO
Tags MREO News General
From Benzinga
After Denying Data Leak, Olema Shares First Data For Lead Program In Breast Cancer Patients
Tickers OLMA
Tags Health Care Biotech Small Cap
From Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
Tickers HOTH
Tags Market News Benzinga HOTH
From Benzinga
Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors
Tickers ADAG MRK
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.